Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.

Clinical trial NCT04614493 · UNKNOWN

Trial details

NCT number: NCT04614493
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Initial Radiological Diagnosis Eligible for Tumor Resection Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide

Start date: 2021-09-11
Primary completion: 2024-03-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.